WeVote
Log In

Bill

Bill

HB 1115

Maryland Pediatric Cancer Fund - Funding

2025 Regular Session Introduced by Sandy Rosenberg

Maryland bill establishing dedicated state fund for pediatric cancer research, treatment, and patient services; withdrawn by sponsor February 2025.

Withdrawn by Sponsor
0
WeVote Research Nonpartisan
Bill Summary · HB 1115

Legislative bill overview

HB 1115 would establish a dedicated fund in Maryland to support pediatric cancer research, treatment, and patient services. The bill allocates state resources specifically toward improving outcomes for children diagnosed with cancer through grants, research initiatives, and clinical support programs.

Why is this important

Pediatric cancer remains a leading disease-related cause of death in children, and specialized funding can accelerate research into rare pediatric cancers while improving access to advanced treatments. Dedicated state funding demonstrates commitment to this vulnerable population and can complement federal research dollars and private donations.

Potential points of contention

  • Budget constraints: State funding allocations require difficult choices among competing public health priorities, and dedicated funds may face scrutiny during budget shortfalls
  • Fund sustainability: Questions about long-term revenue sources and whether dedicated funds are maintained or redirected during fiscal pressures
  • Implementation efficiency: Determining how funds are distributed among research, direct patient care, and administrative costs, and whether state-level programs duplicate existing national initiatives

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.